AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
YD Bio Limited Ordinary Shares
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI AK-C1684E2CA4
4.95▲ 0.71 (16.75%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
4.24
Day's Range
4.14 – 5.10
52-Week Range
1.70 – 18.57
Volume
104.9K
Avg Volume
410.3K
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
2025-08-29
Share count as of June 30, 2026

YD Bio Limited Ordinary Shares (YDES) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about YD Bio Limited Ordinary Shares (YDES)
What is YD Bio Limited Ordinary Shares's Market Cap?
YD Bio Limited Ordinary Shares's Market Cap is $350.7M, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's Enterprise Value?
YD Bio Limited Ordinary Shares's Enterprise Value is $344.7M, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's Price / Sales?
YD Bio Limited Ordinary Shares's Price / Sales is 587.6×, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's EV / Revenue?
YD Bio Limited Ordinary Shares's EV / Revenue is 577.5×, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's EV / EBITDA?
YD Bio Limited Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's Revenue (TTM)?
YD Bio Limited Ordinary Shares's Revenue (TTM) is $596.8K, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's Net Income (TTM)?
YD Bio Limited Ordinary Shares's Net Income (TTM) is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's EBITDA?
YD Bio Limited Ordinary Shares's EBITDA is -$5.3M, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's Diluted EPS (TTM)?
YD Bio Limited Ordinary Shares's Diluted EPS (TTM) is -0.12, based on as-reported figures from SEC (XBRL) filings.
What is YD Bio Limited Ordinary Shares's EBITDA Margin?
YD Bio Limited Ordinary Shares's EBITDA Margin is -880.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · YDESAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(as filed, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023
Revenue
YoY growth+16.9%
Cost of revenue
Gross profit
% of revenue28.1%
Operating expenses
General and administrative expenses
Selling and marketing expenses
Research and development expenses
Impairment of expected credit loss
Total operating expenses
% of revenue911.4%
Loss from operations
% of revenue-883.3%
Other income
Other income, net
Interest income
Total other income, net
Income (Loss) before income tax
Income tax benefit
Net income(loss)
% of revenue-1392.6%
Basic net income (loss) per share (in Dollars per share)
Diluted net income (loss) per share (in Dollars per share)